Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
CALL
GitLab
GTLB
$7.32B
| $1.88M | ﹤0.01% |
50,000
+1,800
| +4% | +$77.9K |
|
2952
Lexeo Therapeutics
LXEO
$407M
| $1.87M | ﹤0.01% |
188,754
+77,175
| +69% | +$704K |
|
2953
Douglas Dynamics
PLOW
$967M
| $1.87M | ﹤0.01% |
57,184
+4,631
| +9% | +$146K |
|
2954
Ethan Allen Interiors
ETD
$583M
| $1.86M | ﹤0.01% |
81,597
-71,403
| -47% | -$1.78M |
|
2955
Heritage Insurance Holdings
HRTG
$989M
| $1.86M | ﹤0.01% |
63,612
+7,674
| +14% | +$207K |
|
2956
Donnelley Financial Solutions
DFIN
$1.22B
| $1.86M | ﹤0.01% |
39,858
+1,882
| +5% | +$91K |
|
2957
Kosmos Energy
KOS
$1.51B
| $1.86M | ﹤0.01% |
2,048,284
-13,628
| -0.7% | -$18K |
|
2958
South Plains Financial
SPFI
$859M
| $1.86M | ﹤0.01% |
47,861
+1,487
| +3% | +$56.9K |
|
2959
Cohu
COHU
$2.76B
| $1.86M | ﹤0.01% |
79,770
+7,840
| +11% | +$180K |
|
2960
Myriad Genetics
MYGN
$303M
| $1.86M | ﹤0.01% |
301,788
+12,591
| +4% | +$91.3K |
|
2961
Mativ Holdings
MATV
$667M
| $1.85M | ﹤0.01% |
152,447
+4,809
| +3% | +$56.7K |
|
2962
Oxford Industries
OXM
$542M
| $1.85M | ﹤0.01% |
54,140
+2,045
| +4% | +$76.1K |
|
2963
Savara
SVRA
$1.08B
| $1.85M | ﹤0.01% |
306,940
+130,424
| +74% | +$639K |
|
|
BBNX
2964
Beta Bionics
BBNX
$813M
| $1.85M | ﹤0.01% |
60,664
+6,250
| +11% | +$167K |
|
2965
ZTO Express
ZTO
$17.4B
| $1.84M | ﹤0.01% |
88,162
+42,081
| +91% | +$833K |
|
2966
Helix Energy Solutions
HLX
$1.49B
| $1.84M | ﹤0.01% |
293,615
+51,380
| +21% | +$341K |
|
2967
PUT
AstraZeneca
AZN
$244B
| $1.84M | ﹤0.01% |
10,000
| – | – |
|
2968
Virtus Investment Partners
VRTS
$1.14B
| $1.84M | ﹤0.01% |
11,253
+1,265
| +13% | +$214K |
|
2969
Cerus
CERS
$572M
| $1.83M | ﹤0.01% |
890,741
-230,186
| -21% | -$399K |
|
2970
Safety Insurance
SAFT
$1.52B
| $1.83M | ﹤0.01% |
23,518
+2,032
| +9% | +$150K |
|
|
UNIT
2971
Uniti Group
UNIT
$2.38B
| $1.83M | ﹤0.01% |
261,248
+59,684
| +30% | +$378K |
|
2972
EverQuote
EVER
$864M
| $1.83M | ﹤0.01% |
67,790
+834
| +1% | +$20.2K |
|
|
GLDD
2973
DELISTED
Great Lakes Dredge & Dock
GLDD
| $1.83M | ﹤0.01% |
139,300
+13,360
| +11% | +$165K |
|
2974
PUT
Western Digital
WDC
$168B
| $1.83M | ﹤0.01% |
10,600
+1,300
| +14% | +$197K |
|
|
ONT
2975
Onterris Inc
ONT
$615M
| $1.82M | ﹤0.01% |
73,486
+23,781
| +48% | +$628K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.